SECsense Logo

GRI Bio, Inc. 8-K Filing Report: Key Insights from February 11, 2025

$GRI
Form 8-K
Filed on: 2025-02-11
Source
GRI Bio, Inc. 8-K Filing Report: Key Insights from February 11, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: GRI Bio, Inc.
  • SEC CIK Number: 0001824293
  • Entity Type: Corporation (DE - Delaware)
  • IRS Employer Identification Number: 82-4369909
  • Address: 2223 Avenida de la Playa, Suite 208, La Jolla, CA 92037
  • Contact Phone: 619-400-1170
  1. Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: February 11, 2025
  • Period Covered: February 11, 2025 (single-day reporting)
  1. Securities Information:
  • Security Type: Common Stock
  • Par Value: $0.0001 per share
  1. Additional Metadata:
  • The document is in XBRL format, indicating it is structured for financial reporting and analysis.
  • The schema reference indicates compliance with XBRL standards.

Summary:

The report is an 8-K filing by GRI Bio, Inc. on February 11, 2025, covering a specific event or change that occurred on that date. The entity is incorporated in Delaware and deals with common stock valued at a nominal par value. The document follows XBRL standards for reporting, which enhances its accessibility for financial analysis.